Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
Patients with MASH experience worse health-related quality of life: a multinational real-world study using LiverMultiScan
Par Shumbayawonda E, Utsav M, Hancock M et 18 autres.
Contenu en anglais
Résumé
Purpose
Prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH), is increasing globally. Assessment of health-related quality of life (HRQoL), alongside non-invasive tests (NITs), may support identification of patients requiring closer clinical management. This multinational real-world randomised controlled trial evaluated associations between HRQoL (using the EQ-5D) and multiparametric MRI (mpMRI) markers of liver disease.